<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Mucosal administration (ocular, nasal, oral, vaginal) still represents a challenging route due to the presence of mucus, lacrimal fluids, and saliva, which can impair the bioavailability of the bioactive compound [
 <xref rid="B19-biomolecules-09-00138" ref-type="bibr" class="xref">19</xref>]. However, it is possible to foresee the development of mucoadhesive formulations as means to overcome these limitations.
</p>
